Perioperative anesthesiological management of patients with pulmonary hypertension

Anesthesiology Research and Practice

Volumn 2012, Issue , 2012, Pages

  Gille, Jochen ^a   Seyfarth, Hans Jürgen ^b   Gerlach, Stefan ^a   Malcharek, Michael ^a   Czeslick, Elke ^c   Sablotzki, Armin ^a  

^a Klinikum St Georg   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMBRISENTAN; ANESTHETIC AGENT; ANTICOAGULANT AGENT; BOSENTAN; CYCLIC GMP; DIURETIC AGENT; DOBUTAMINE; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; ETOMIDATE; FENTANYL; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; ILOPROST; ISOFLURANE; MILRINONE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROPOFOL; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; SILDENAFIL; SUFENTANIL; TADALAFIL; THIOPENTAL; TREPROSTINIL; UNINDEXED DRUG; VASODILATOR AGENT;

ANALGESIA; ANESTHESIA; ANESTHESIA INDUCTION; ANESTHESIA MECHANISM; ANESTHESIOLOGICAL PROCEDURE; ANESTHESIST; ANESTHETIC RECOVERY; CARDIOLOGIST; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL EXAMINATION; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG APPROVAL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG INDICATION; DRUG WITHDRAWAL; EDEMA; ELECTROCARDIOGRAM; ERGOMETRY; EXERCISE TEST; FLUSHING; HEADACHE; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMIC PARAMETERS; HUMAN; HYPERCAPNIA; HYPERVOLEMIA; HYPOTENSION; HYPOTHERMIA; HYPOXEMIA; IDIOPATHIC DISEASE; INHALATION ANESTHESIA; INTRAVENOUS ANESTHESIA; LIMB PAIN; LIVER FUNCTION TEST; LIVER TOXICITY; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; MEDICAL SPECIALIST; MONOTHERAPY; MORBIDITY; MORTALITY; OXYGEN THERAPY; PAIN; PATIENT MONITORING; PERIOPERATIVE PERIOD; PERIPHERAL EDEMA; PEROPERATIVE COMPLICATION; POSTOPERATIVE CARE; PREVALENCE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULMONOLOGIST; RECOMMENDED DRUG DOSE; REFLUX ESOPHAGITIS; REPEATED DRUG DOSE; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SIDE EFFECT; SINGLE DRUG DOSE; SPIROMETRY; SURGEON; SURGICAL PATIENT; SURVIVAL RATE; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; TREATMENT PLANNING; WALKING;

EID: 84869061343     PISSN: 16876962     EISSN: 16876970     Source Type: Journal    
DOI: 10.1155/2012/356982     Document Type: Review

References (94)

1. Ramakrishna G., Sprung J., Ravi B. S., Chandrasekaran K., McGoon M. D., Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. Journal of the American College of Cardiology 2005 45 10 1691 1699 2-s2.0-18944376672 10.1016/j.jacc.2005.02.055 (Pubitemid 40704508)
2. Rodriguez R. M., Pearl R. G., Pulmonary hypertension and major surgery. Anesthesia and Analgesia 1998 87 4 812 815 2-s2.0-0031666094 10.1097/00000539-199810000-00013 (Pubitemid 28455475)
3. Roberts N. V., Keast P. J., Pulmonary hypertension and pregnancya lethal combination. Anaesthesia and Intensive Care 1990 18 3 366 374 2-s2.0-0025090828 (Pubitemid 20280895)
4. Reich D. L., Bodian C. A., Krol M., Kuroda M., Osinski T., Thys D. M., Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesthesia and Analgesia 1999 89 4 814 822 2-s2.0-0032836514 10.1097/00000539-199910000-00002 (Pubitemid 29458450)
5. Shimizu T., Takahashi H., Matsumiya N., Miyabe M., Tanaka M., Unsuccessful anesthetic management for cesarean section in a patient with primary pulmonary hypertension. Japanese Journal of Anesthesiology 2007 56 8 949 952 2-s2.0-34548030714 (Pubitemid 47280289)
6. Kaw R., Pasupuleti V., Deshpande A., Hamieh T., Walker E., Minai O. A., Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery. Respiratory Medicine 2011 105 4 619 624 2-s2.0-79952312084 10.1016/j.rmed.2010.12.006
7. Simonneau G., Robbins I. M., Beghetti M., Channick R. N., Delcroix M., Denton C. P., Elliott C. G., Gaine S. P., Gladwin M. T., Jing Z. C., Krowka M. J., Langleben D., Nakanishi N., Souza R., Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology 2009 54 1, supplement S43 S54 2-s2.0-67649579669 10.1016/j.jacc.2009.04.012
8. Galiè N., Hoeper M.M., Humbert M., Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS), endorsed by the international society of heart and lung transplantation (ISHLT). European Heart Journal 2009 30 20 2493 2537
9. Kovacs G., Maier R., Aberer E., Brodmann M., Scheidl S., Tröster N., Hesse C., Salmhofer W., Graninger W., Gruenig E., Rubin L. J., Olschewski H., Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. American Journal of Respiratory and Critical Care Medicine 2009 180 9 881 886 2-s2.0-70350454775 10.1164/rccm.200904-0563OC
10. Kovacs G., Berghold A., Scheidl S., Olschewski H., Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. European Respiratory Journal 2009 34 4 888 894 2-s2.0-67649624517 10.1183/09031936.00145608
11. Morrell N. W., Adnot S., Archer S. L., Dupuis J., Lloyd Jones P., MacLean M. R., McMurtry I. F., Stenmark K. R., Thistlethwaite P. A., Weissmann N., Yuan J. X. J., Weir E. K., Cellular and molecular basis of pulmonary arterial hypertension. Journal of the American College of Cardiology 2009 54 1, supplement S20 S31 2-s2.0-67649599147 10.1016/j.jacc.2009.04.018
12. Humbert M., Sitbon O., Chaouat A., Bertocchi M., Habib G., Gressin V., Yaici A., Weitzenblum E., Cordier J. F., Chabot F., Dromer C., Pison C., Reynaud-Gaubert M., Haloun A., Laurent M., Hachulla E., Simonneau G., Pulmonary arterial hypertension in France: results from a national registry. American Journal of Respiratory and Critical Care Medicine 2006 173 9 1023 1030 2-s2.0-33646269035 10.1164/rccm.200510-1668OC
13. Pengo V., Lensing A. W. A., Prins M. H., Marchiori A., Davidson B. L., Tiozzo F., Albanese P., Biasiolo A., Pegoraro C., Iliceto S., Prandoni P., Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. The New England Journal of Medicine 2004 350 22 2257 2364 2-s2.0-2442643903 10.1056/NEJMoa032274 (Pubitemid 38669208)
14. Thabut G., Dauriat G., Stern J. B., Logeart D., Levy A., Marrash-Chahla R., Mal H., Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005 127 5 1531 1536 2-s2.0-19844369633 10.1378/chest.127.5.1531 (Pubitemid 46218776)
15. Hoeper Mm, Andreas S., Bastian A., Pulmonale Hypertonie bei chronischen Lungenerkrankungen. Empfehlungen der Kölner Konsensus-Konferenz 2010. Deutsche Medizinische Wochenschrift 2010 135 115 124
16. Westby C. M., Weil B. R., Greiner J. J., Stauffer B. L., DeSouza C. A., Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men. Clinical Science 2011 120 11 485 491 2-s2.0-79952344718 10.1042/CS20100475
17. Rubin L. J., Badesch D. B., Barst R. J., Galiè N., Black C. M., Keogh A., Pulido T., Frost A., Roux S., Leconte I., Landzberg M., Simonneau G., Bosentan therapy for pulmonary arterial hypertension. The New England Journal of Medicine 2002 346 12 896 903 2-s2.0-0037149718 10.1056/NEJMoa012212 (Pubitemid 34984638)
18. Humbert M., Segal E. S., Kiely D. G., Carlsen J., Schwierin B., Hoeper M. M., Results of European post-marketing surveillance of bosentan in pulmonary hypertension. European Respiratory Journal 2007 30 2 338 344 2-s2.0-34547558919 10.1183/09031936.00138706 (Pubitemid 47194187)
19. Galiè N., Olschewski H., Oudiz R. J., Torres F., Frost A., Ghofrani H. A., Badesch D. B., McGoon M. D., McLaughlin V. V., Roecker E. B., Gerber M. J., Dufton C., Wiens B. L., Rubin L. J., Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-Blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation 2008 117 23 3010 3019 2-s2.0-46449124591 10.1161/CIRCULATIONAHA.107.742510
20. Rubin L. J., Badesch D. B., Fleming T. R., Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: SUPER-2. Chest 2011 140 5 1274 1283
21. Galiè N., Brundage B. H., Ghofrani H. A., Oudiz R. J., Simonneau G., Safdar Z., Shapiro S., White R. J., Chan M., Beardsworth A., Frumkin L., Barst R. J., Tadalafil therapy for pulmonary arterial hypertension. Circulation 2009 119 22 2894 2903 2-s2.0-67649523052 10.1161/CIRCULATIONAHA.108.839274
22. Olschewski H., Simonneau G., Galie N., Inhaled iloprost for severe pulmonary hypertension. The New England Journal of Medicine 2002 347 5 322 329 10.1056/NEJMoa020204 (Pubitemid 34815354)
23. Gomberg-Maitland M., Olschewski H., Prostacyclin therapies for the treatment of pulmonary arterial hypertension. European Respiratory Journal 2008 31 4 891 901 2-s2.0-42949166212 10.1183/09031936.00097107
24. Jaïs X., D'Armini A. M., Jansa P., Torbicki A., Delcroix M., Ghofrani H. A., Hoeper M. M., Lang I. M., Mayer E., Pepke-Zaba J., Perchenet L., Morganti A., Simonneau G., Rubin L. J., Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension. BENEFiT (bosentan effects in inoperable forms of chronic thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. Journal of the American College of Cardiology 2008 52 25 2127 2134 2-s2.0-57449103127 10.1016/j.jacc.2008.08.059
25. Seyfarth H. J., Halank M., Wilkens H., Schäfers H. J., Ewert R., Riedel M., Schuster E., Pankau H., Hammerschmidt S., Wirtz H., Standard PAH therapy improves long term survival in CTEPH patients. Clinical Research in Cardiology 2010 99 9 553 556 2-s2.0-77957983646 10.1007/s00392-010-0156-4
26. Subramaniam K., Yared J. P., Management of pulmonary hypertension in the operating room. Seminars in Cardiothoracic and Vascular Anesthesia 2007 11 2 119 136 2-s2.0-34249803583 10.1177/1089253207301733 (Pubitemid 46848532)
27. Preckel B., Eberl S., Fraessdorf J., Management of patients with pulmonary hypertension. Anaesthesist 2012 61 7 574 587 10.1007/s00101-012-2040-2
28. McLaughlin V. V., Archer S. L., Badesch D. B., Barst R. J., Farber H. W., Lindner J. R., Mathier M. A., McGoon M. D., Park M. H., Rosenson R. S., Rubin L. J., Tapson V. F., Varga J., ACCF/AHA 2009 expert consensus document on pulmonary hypertension. A report of the American college of cardiology foundation task force on expert consensus documents and the American heart association developed in collaboration with the American college of chest physicians; American thoracic society, Inc.; and the pulmonary hypertension association. Journal of the American College of Cardiology 2009 53 17 1573 1619 2-s2.0-64849109410 10.1016/j.jacc.2009.01.004
29. Gruenig E., Barner A., Bell M., Nichtinvasive Diagnostik der pulmonalen Hypertonie. ESC/ERS-Leitlinien mit Kommentierung der Kölner Konsenus-Konferenz 2010. Deutsche Medizinische Wochenschrift 2010 135 67 77
30. Fischer L. G., van Aken H., Bürkle H., Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesthesia and Analgesia 2003 96 6 1603 1616 2-s2.0-0038024481 (Pubitemid 36623112)
31. Fox C., Kalarickal P. L., Yarborough M. J., Jin J. Y., Perioperative management including new pharmacological vistas for patients with pulmonary hypertension for noncardiac surgery. Current Opinion in Anaesthesiology 2008 21 4 467 472 2-s2.0-66449136428 10.1097/ACO.0b013e3283007eb4
32. Hofer C. K., Senn A., Weibel L., Assessment of stroke volume variation for prediction of fluid responsiveness using the modified FloTrac and PiCCOplus system. Critical Care 2008 12, article R82 10.1186/cc6933 (Pubitemid 351974298)
33. Schulmeyer Mcc, Santelices E., Vega R., Impact of intraoperative transesophageal echocardiography during noncardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia 2006 20 6 768 771 10.1053/j.jvca.2006.05. 004 (Pubitemid 44816496)
34. Kolev N., Brase R., Swanevelder J., Oppizzi M., Riesgo M. J., van der Maaten J. M. A. A., Abiad M. G., Guarracino F., Zimpfer M., The influence of transoesophageal echocardiography on intra-operative decision making. A European multicentre study. Anaesthesia 1998 53 8 767 773 2-s2.0-0031872082 10.1046/j.1365-2044.1998.00341.x (Pubitemid 28391383)
35. Hofer C. K., Zollinger A., Rak M., Matter-Ensner S., Klaghofer R., Pasch T., Zalunardo M. P., Therapeutic impact of intra-operative transoesophageal echocardiography during noncardiac surgery. Anaesthesia 2004 59 1 3 9 2-s2.0-0345865598 10.1111/j.1365-2044.2004.03459.x (Pubitemid 38081218)
36. Poelaert J. I., Trouerbach J., de Buyzere M., Everaert J., Colardyn F. A., Evaluation of transesophageal echocardiography as a diagnostic and therapeutic aid in a critical care setting. Chest 1995 107 3 774 779 2-s2.0-0028956145
37. Rinne T., Zwissler B., Intraoperative anesthetic management in patients with pulmonary hypertension. Intensiv-und Notfallbehandlung 2004 29 1 4 13 2-s2.0-2342572768 (Pubitemid 38596022)
38. Krug S., Sablotzki A., Hammerschmidt S., Wirtz H., Seyfarth H. J., Inhaled iloprost for the control of pulmonary hypertension. Vascular Health and Risk Management 2009 5 465 474 2-s2.0-67449108485
39. Crowley R., Sanchez E., Ho J. K., Prolonged central venous desaturation measured by continuous oximetry is associated with adverse outcomes in pediatric cardiac surgery. Anesthesiology 2011 115 5 1033 1043 10.1097/ALN. 0b013e318233056e
40. 2 in critically ill patients ? Cardiology Research and Practice 2012 2012 7 370697 10.1155/2012/370697
41. Pritts C. D., Pearl R. G., Anesthesia for patients with pulmonary hypertension. Current Opinion in Anaesthesiology 2010 23 3 411 416 2-s2.0-77951987401 10.1097/ACO.0b013e32833953fb
42. Jenkins J., Lynn A., Edmonds J., Barker G., Effects of mechanical ventilation on cardiopulmonary function in children after open-heart surgery. Critical Care Medicine 1985 13 2 77 80 2-s2.0-0021994901 (Pubitemid 15174130)
43. Von Dossow V., Welte M., Zaune U., Martin E., Walter M., Rückert J., Kox W. J., Spies C. D., Thoracic epidural anesthesia combined with general anesthesia: the preferred anesthetic technique for thoracic surgery. Anesthesia and Analgesia 2001 92 4 848 854 2-s2.0-0035084253 (Pubitemid 32239121)
44. Veering B. T., Cousins M. J., Cardiovascular and pulmonary effects of epidural anaesthesia. Anaesthesia and Intensive Care 2000 28 6 620 635 2-s2.0-0034521291 (Pubitemid 32040830)
45. Pollard J. B., Common mechanisms and strategies for prevention and treatment of cardiac arrest during epidural anesthesia. Journal of Clinical Anesthesia 2002 14 1 52 56 2-s2.0-0036179259 10.1016/S0952-8180(01)00355-5 (Pubitemid 34173614)
46. Bonnin M., Mercier F. J., Sitbon O., Roger-Christoph S., Jaïs X., Humbert M., Audibert F., Frydman R., Simonneau G., Benhamou D., Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005 102 6 1133 1137 2-s2.0-21144466750 10.1097/00000542-200506000-00012 (Pubitemid 40745831)
47. Kiely D. G., Condliffe R., Webster V., Mills G. H., Wrench I., Gandhi S. V., Selby K., Armstrong I. J., Martin L., Howarth E. S., Bu'Lock F. A., Stewart P., Elliot C. A., Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. BJOG: An International Journal of Obstetrics and Gynaecology 2010 117 5 565 574 2-s2.0-77949279115 10.1111/j.1471-0528.2009. 02492.x
48. Gogarten W., Vandermeulen E., van Aken H., Kozek S., Llau J. V., Samama C. M., Regional anaesthesia and antithrombotic agents: recommendations of the European society of anaesthesiology. European Journal of Anaesthesiology 2010 27 12 999 1015 2-s2.0-78349242482 10.1097/EJA.0b013e32833f6f6f
49. Horlocker T. T., Wedel D. J., Rowlingson J. C., Enneking F. K., Kopp S. L., Benzon H. T., Brown D. L., Heit J. A., Mulroy M. F., Rosenquist R. W., Tryba M., Yuan C. S., Regional Anesthesia in the patient receiving antithrombotic or thrombolytic therapy; American society of regional anesthesia and pain medicine evidence-based guidelines (third edition). Regional Anesthesia and Pain Medicine 2010 35 1 64 101 2-s2.0-74549191939 10.1097/AAP.0b013e3181c15c70
50. Blaise G., Langleben D., Hubert B., Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology 2003 99 6 1415 1432 2-s2.0-0344851838 10.1097/00000542-200312000-00027 (Pubitemid 37475190)
51. Mertens E., Saldien V., Coppejans H., Bettens K., Vercauteren M., Target controlled infusion of remifentanil and propofol for cesarean section in a patient with multivalvular disease and severe pulmonary hypertension. Acta Anaesthesiologica Belgica 2001 52 2 207 209 2-s2.0-0034862045 (Pubitemid 32803380)
52. Rich G. F., Roos C. M., Anderson S. M., Daugherty M. O., Uncles D. R., Direct effects of intravenous anesthetics on pulmonary vascular resistance in the isolated rat lung. Anesthesia and Analgesia 1994 78 5 961 966 2-s2.0-0028297751 (Pubitemid 24138275)
53. Gambone L. M., Murray P. A., Flavahan N. A., Isoflurane anesthesia attenuates endotheliumdependent pulmonary vasorelaxation by inhibiting the synergistic interaction between nitric oxide and prostacyclin. Anesthesiology 1997 86 4 936 944 2-s2.0-0030949776
54. Nakayama M., Kondo U., Murray P. A., Pulmonary vasodilator response to adenosine triphosphatesensitive potassium channel activation is attenuated during desflurane but preserved during sevoflurane anesthesia compared with the conscious state. Anesthesiology 1998 88 4 1023 1035 2-s2.0-0031896793 10.1097/00000542-199804000-00023 (Pubitemid 28193330)
55. Hickey P. R., Hansen D. D., Cramolini G. M., Vincent R. N., Lang P., Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 1985 62 3 287 293 2-s2.0-0021922190 (Pubitemid 15101878)
56. Wiedemann K., Diestelhorst C., The effect of sedation on pulmonary function. Anaesthesist 1995 44 supplement 3 S588 S593 2-s2.0-0029591505
57. Tempe D., Mohan J. C., Cooper A., Myocardial depressant effect of nitrous oxide after valve surgery. European Journal of Anaesthesiology 1994 11 353 358
58. Williams G. D., Maan H., Ramamoorthy C., Kamra K., Bratton S. L., Bair E., Kuan C. C., Hammer G. B., Feinstein J. A., Perioperative complications in children with pulmonary hypertension undergoing general anesthesia with ketamine. Paediatric Anaesthesia 2010 20 1 28 37 2-s2.0-73649126567 10.1111/j.1460-9592.2009.03166.x
59. Price L. C., Wort S. J., Finney S. J., Marino P. S., Brett S. J., Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Critical Care 2010 14 5, article 169 2-s2.0-77956671273 10.1186/cc9264
60. Stobierska-Dzierzek B., Awad H., Michler R. E., The evolving management of acute right-sided heart failure in cardiac transplant recipients. Journal of the American College of Cardiology 2001 38 4 923 931 2-s2.0-0034810366 10.1016/S0735-1097(01)01486-3 (Pubitemid 32912691)
61. Carl M., Alms A., Braun J., S3 guidelines for intensive care in cardiac surgery patients: hemodynamic monitoring and cardiocirculatory system. German Medical Science 2010 8 Doc12 10.3205/000101
62. Teo Y. W., Greenhalgh D. L., Update on anaesthetic approach to pulmonary hypertension. European Journal of Anaesthesiology 2010 27 4 317 323 2-s2.0-77951983142 10.1097/EJA.0b013e328335474e
63. Czeslick E., Hentschel T., Friedrich I., Inhalierbare Vasodilatatoren in der kardiochirurgischen Intensivmedizin. Zeitschrift für Herz-,Thorax-und Gefächirurgie 2005 19 132 145
64. Forrest P., Anaesthesia and right ventricular failure. Anaesthesia and Intensive Care 2009 37 3 370 385 2-s2.0-66449134538
65. Chen E. P., Bittner H. B., Davis R. D., van Trigt P., Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Annals of Thoracic Surgery 1997 63 3 814 821 2-s2.0-0030964064 10.1016/S0003-4975(97)00011-8 (Pubitemid 27128706)
66. Vizza C. D., Rocca G. D., Roma D. A., Iacoboni C., Pierconti F., Venuta F., Rendina E., Schmid G., Pietropaoli P., Fedele F., Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. Critical Care 2001 5 6 355 361 2-s2.0-18244400291 10.1186/cc1069 (Pubitemid 34130338)
67. Walmrath D., Schermuly R., Pilch J., Grimminger F., Seeger W., Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. European Respiratory Journal 1997 10 5 1084 1092 2-s2.0-0030958618 (Pubitemid 27201814)
68. Pepke-Zaba J., Higenbottam T. W., Dinh-Xuan A. T., Stone D., Wallwork J., Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. The Lancet 1991 338 8776 1173 1174 2-s2.0-0026002659 10.1016/0140-6736(91)92033-X
69. Steudel W., Hurford W. E., Zapol W. M., Inhaled nitric oxide: basic biology and clinical applications. Anesthesiology 1999 91 4 1090 1121 2-s2.0-0032848791 10.1097/00000542-199910000-00030 (Pubitemid 29466545)
70. Hurford W. E., Bigatello L. M., NO-body's perfect. Anesthesiology 2002 96 6 1285 1287 2-s2.0-0036263480 10.1097/00000542-200206000-00003 (Pubitemid 34587192)
71. Ibrahim Y. I., Ninnis J. R., Hopper A. O., Inhaled nitric oxide therapy increases blood nitrite, nitrate, and s-nitrosohemoglobin concentrations in infants with pulmonary hypertension. Journal of Pediatrics 2012 160 2 245 251 10.1016/j.jpeds.2011.07.040
72. Walmrath D., Schneider T., Schermuly R., Olschewski H., Grimminger F., Seeger W., Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 1996 153 3 991 996 2-s2.0-0029880173 (Pubitemid 26081651)
73. Schroeder R. A., Wood G. L., Plotkin J. S., Kuo P. C., Intraoperative use of inhaled PGI2 for acute pulmonary hypertension and right ventricular failure. Anesthesia and Analgesia 2000 91 2 291 295 2-s2.0-0033865282 (Pubitemid 30624283)
74. Haché M., Denault A. Y., Bélisle S., Couture P., Babin D., Tétrault F., Guimond J. G., Inhaled prostacyclin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit. Canadian Journal of Anesthesia 2001 48 9 924 929 2-s2.0-0034747517 (Pubitemid 33150289)
75. Winterhalter M., Antoniou T., Loukanov T., Management of adult patients with perioperative pulmonary hypertension: technical aspects and therapeutic options. Cardiology 2010 116 1 3 9 2-s2.0-77951248351 10.1159/000313863
76. Rex S., Busch T., Vettelschoss M., de Rossi L., Rossaint R., Buhre W., Intraoperative management of severe pulmonary hypertension during cardiac surgery with inhaled iloprost. Anesthesiology 2003 99 3 745 747 2-s2.0-0042324889 10.1097/00000542-200309000-00033 (Pubitemid 37051993)
77. Kramm T., Eberle B., Guth S., Mayer E., Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. European Journal of Cardio-Thoracic Surgery 2005 28 6 882 888 2-s2.0-28444432284 10.1016/j.ejcts.2005.09.007 (Pubitemid 41735269)
78. Gessler T., Schmehl T., Hoeper M. M., Rose F., Ghofrani H. A., Olschewski H., Grimminger F., Seeger W., Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension. European Respiratory Journal 2001 17 1 14 19 2-s2.0-0034954724 10.1183/09031936.01.17100140 (Pubitemid 32600551)
79. Loukanov T., Bucsenez D., Springer W., Sebening C., Rauch H., Roesch E., Karck M., Gorenflo M., Comparison of inhaled nitric oxide with aerosolized iloprost for treatment of pulmonary hypertension in children after cardiopulmonary bypass surgery. Clinical Research in Cardiology 2011 100 7 595 602 2-s2.0-79751527719 10.1007/s00392-011-0284-5
80. Krug S., Hammerschmidt S., Pankau H., Wirtz H., Seyfarth H. J., Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension. Respiration 2008 76 2 154 159 2-s2.0-49949112962 10.1159/000107977
81. Yurtseven N., Karaca P., Uysal G., Ozkul V., Cimen S., Tuygun A. K., Yuksek A., Canik S., A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery. Annals of Thoracic and Cardiovascular Surgery 2006 12 5 319 323 2-s2.0-39049181746
82. Elliot C. A., Stewart P., Webster V. J., Mills G. H., Hutchinson S. P., Howarth E. S., Bu'Lock F. A., Lawson R. A., Armstrong I. J., Kiely D. G., The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. European Respiratory Journal 2005 26 1 168 173 2-s2.0-21744442457 10.1183/09031936.05.00128504 (Pubitemid 40945946)
83. Haraldsson A., Kieler-Jensen N., Ricksten S. E., The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension. Anesthesia and Analgesia 2001 93 6 1439 1445 2-s2.0-0035197129 (Pubitemid 33111666)
84. Lamarche Y., Perrault L. P., Maltais S., Tétreault K., Lambert J., Denault A. Y., Preliminary experience with inhaled milrinone in cardiac surgery. European Journal of Cardio-thoracic Surgery 2007 31 6 1081 1087 2-s2.0-34248366457 10.1016/j.ejcts.2007.02.019 (Pubitemid 46729654)
85. Sablotzki A., Startzmann W., Scheubel R., Grond S., Czeslick E. G., Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates. Canadian Journal of Anesthesia 2005 52 10 1076 1082 2-s2.0-32044468039
86. Ghofrani H. A., Rose F., Schermuly R. T., Olschewski H., Wiedemann R., Weissmann N., Schudt C., Tenor H., Seeger W., Grimminger F., Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension. Critical Care Medicine 2002 30 11 2489 2492 2-s2.0-0036852964 (Pubitemid 35351868)
87. Wang H., Gong M., Zhou B., Dai A., Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery. Advances in Therapy 2009 26 4 462 468 2-s2.0-73449126557 10.1007/s12325-009-0019-4
88. Huang J., Bouvette M. J., Zhou J., Simultaneous delivery of inhaled prostacyclin and milrinone through a double nebulizer system. Journal of Cardiothoracic and Vascular Anesthesia 2011 25 3 590 591 2-s2.0-79957711089 10.1053/j.jvca.2010.08.002
89. Simonneau G., Barst R. J., Galie N., Naeije R., Rich S., Bourge R. C., Keogh A., Oudiz R., Frost A., Blackburn S. D., Crow J. W., Rubin L. J., Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. American Journal of Respiratory and Critical Care Medicine 2002 165 6 800 804 2-s2.0-0037086133 (Pubitemid 34229650)
90. Levarge B. L., Channick R. N., Inhaled treprostinil for the treatment of pulmonary arterial hypertension. Expert Review of Respiratory Medicine 2012 6 3 255 265 10.1586/ers.12.23
91. Channick R. N., Voswinckel R., Rubin L. J., Inhaled treprostinil: a therapeutic review. Drug Design, Development and Therapy 2012 6 19 28
92. Voswinckel R., Enke B., Reichenberger F., Kohstall M., Kreckel A., Krick S., Gall H., Gessler T., Schmehl T., Ghofrani H. A., Schermuly R. T., Grimminger F., Rubin L. J., Seeger W., Olschewski H., Favorable effects of inhaled treprostinil in severe pulmonary hypertension. Results from randomized controlled pilot studies. Journal of the American College of Cardiology 2006 48 8 1672 1681 2-s2.0-33749537060 10.1016/j.jacc.2006.06.062 (Pubitemid 44528194)
93. Loh E., Stamler J. S., Hare J. M., Loscalzo J., Colucci W. S., Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994 90 6 2780 2785 2-s2.0-0028610499
94. Semigran M. J., Cockrill B. A., Kacmarek R., Thompson B. T., Zapol W. M., Dec G. W., Fifer M. A., Hemodynamic effects of inhaled nitric oxide in heart failure. Journal of the American College of Cardiology 1994 24 4 982 988 2-s2.0-0028070791 (Pubitemid 24306408)